Deregulated apoptosis in ataxia telangiectasia: Association with clinical stigmata and radiosensitivity

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1400-1404

  Duchaud, Eric ^a   Ridet, Agnes ^a   Stoppa Lyonnet, Dominique ^a   Janin, Nicolas ^b   Moustacchi, Ethel ^a   Rosselli, Filippo ^a  

^a INSTITUT CURIE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; EPSTEIN BARR VIRUS; GAMMA IRRADIATION; GENETIC REGULATION; HUMAN; HUMAN CELL; IONIZING RADIATION; LYMPHOBLAST; PHENOTYPE; PRIORITY JOURNAL; RADIOSENSITIVITY; VIRUS TRANSFORMATION;

APOPTOSIS; ATAXIA TELANGIECTASIA; CELL LINE; CELL LINE, TRANSFORMED; FAMILY; FIBROBLASTS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES; TIME FACTORS;

EID: 0029987944     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kastan, M B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage Cancer Res., 51: 6304-6311, 1991.
2. Fritsche, M., Haessler, C., and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8: 307-318, 1993.
3. Kuerbitz, S J., Plunkett, B. S , Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad Sci USA, 89: 7491-7495, 1992.
4. Clarke, A. R., Purdie, C. A , Harrison, D. J., Morris, R. G., ,Bird C. C., Hooper, M. L., and Wyllie, A H. Thymocyte apoptosis induced by p53-dependent and independent pathways Nature (Lond.), 362, 849-852, 1993.
5. Lotem, J , and Sachs, L Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82: 1092-1096, 1993.
6. Lowe, S. W , Schmitt, E M , Smith, S. W , Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
7. Di Leonardo, A., Linke, S. P., Clarkin, K., and Wahl, G. M. DNA damage triggers a prolonged p53-dependent GI arrest and long-term induction of Cip1 in normal human fibroblasts. Genes & Dev., 8: 2540-2551, 1994
8. Strasser, A , Harris, A. W., Jacks, T., and Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell, 79: 329-339, 1994.
9. Kastan, M B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T , Walsh, W. V., Plunkett, B. S., Vogelstein, B , and Fornace, A J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
10. McKinnon, P. J Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Hum. Genet , 75: 197-208, 1987.
11. Painter, R B., and Young B R. Radiosensitivity in ataxia telangiectasia: a new explanation. Proc Natl Acad Sci USA, 77:7315-7317, 1980
12. Beamish, H., and Lavin, M F Radiosensitivity in ataxia telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol , 65. 175-184, 1994.
13. Khanna, K K., and Lavin, M. F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-tetangiectasia. Oncogene, 8: 3307-3312, 1993.
14. Canman, C. E., Wolff, A C , Chen, C. Y., Fornace, A. J., and Kastan, M. B. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res , 54: 5054-5058, 1994.
15. Khanna K K., Beamish H , Hobso K., Williams R., Dunn I, and Lavin M. F. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene, 11: 609-618, 1995
16. Duchaud, E , Ridel, A., Delic, Y., Cundari, E , Moustacchi, E., and Rosselli, F. Radio-induced apoptosis is impaired in individuals homozygous and heterozygous for the ataxia-telangiectasia gene(s). C R. Acad Sci. Paris, 317: 983-989, 1994.
17. Meyn, M S , Strasfeld, L., and Allen, C. Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int. J. Radiat. Biol , 66: S141-S149, 1994
18. Tuosto, L., Cundari, E , Gilardini Montani, M S , and Piccolelle, E. Analysis of susceptibility of mature human lymphocytes to dexamethasone-induced apoptosis Eur. J Immunol., 24. 1061-1065, 1994.
19. Darzynkiewicz, Z , Brono, S D , Del Bino, G , Gorczya, W , Hotz, M A., Lassotta, P., and Traganos, F Features of apoptotic cells measured by Flow-cytometry. Cytometry, 13: 795-808, 1992.
20. Chen, P C., Lavin, M F , Kidson, C , and Moss, D. Identification of ataxia-telangiectasia heterozygotes. A cancer-prone population. Nature (Lond ), 274. 484-486, 1978.
21. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulate the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993
22. Arlett, C F., Green, M H., Priestley, A., Harcourt, S A , and Mayne, L. V. Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int. J. Radiat. Biol., 54: 911-928, 1988.
23. 0) T-lymphocytes: T-lymphocytes lines and fibroblasts from normal donors, from ataxia telangiectasia patients and from ataxia-telangiectasia heterozygotes. Int. J. Radiat. Biol., 54: 929-943, 1988.
24. Raff, M. C. Social controls on cell survival and cell death. Nature (Lond.), 356: 397-399, 1992.
25. Savitsky, K., Bar-Shira, A., Gilad, S , Rotman, G., Ziv, Y., Vanagaite, L., Tagle D. A., Smith S , Uziel T., Sfez S , Ashkenazi M , Pecker I , Frydman, M , Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R A , Chessa, L., Sanal, O , Lavin, M F., Jaspers, N. G. J., Taylor, A. M. R , Arlett, C. F , Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., and Shiloh, Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (Washington DC), 268: 1749-1754, 1995.
26. Yao, R., and Cooper, G. M Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science (Washington DC), 267: 2003-2006, 1995.
27. Swift, M., Chose, C L., and Morell, D. Cancer predisposition of ataxia-telangiectasia heterozygotes Cancer Genet. Cytogenet., 46: 21-27, 1990.
28. Parshad, R., Sanford, K. K., Jones, G. M., and Tarone, R. E G2 chromosomal radiosensitiviry of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet., 14. 163-168, 1985
29. Kinsella, T. J., Mitchell, J. B., McPherson, S., Russo, A., and Tvetze, F. In vitro X-ray sensitivity in ataxia-telangiectasia homozygote and heterozygote skin fibroblasts under oxic and hypoxic conditions Cancer Res., 42: 3950-3956, 1982.
30. Lee, J. M , and Bernstein, A. p53 mutations increase resistance to ionizing radiation Proc. Natl. Acad Sci USA, 90. 5742-5746, 1993.
31. Murnane, J. P., Fuller, L. F., and Painter, R. B. Establishment and characterization of a permanent pSV on-transformed ataxia-telangiectasia cell line. Exp. Cell Res , 158 119-126, 1985.
32. Angel, P , Rahmsdorf H. J., Poting, A., Luke-Huhle, C., and Herrlich, P 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced gene sequences in human primary diploid fibroblasts and their expression in SV40-transformed fibroblasts. J. Cell. Bioehem., 29: 351-360, 1985.
33. Luke-Huhle, C Alterations in oncogene expression and radiosensitivity in the most frequently used SV40-transformed human skin fibroblasts. Int J. Radiat. Biol., 65: 665-673, 1994.
34. Jorgensen, T J , Russell, P. S , and McRae, D. A. Radioresistant DNA synthesis in SV40-immortalized ataxia-telangiectasia fibroblasts. Radiat Res., 143: 219-233, 1995.
35. Su, L. N., and Little, J. B Transformation and radiosensitivity of human diploid skin fibroblasts transfected with SV40 T-antigen mutants defective in RB and p53 binding domains Int. J. Radiat. Biol., 62: 461-468, 1992.